Thomas Davis

Dr. Thomas Davis

Cardiology
24211 Little Mack Ave, 
Saint Clair Shores, MI 
40 Years of Experience
24211 Little Mack Ave, 
Saint Clair Shores, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Davis is a Cardiologist in Saint Clair Shores, Michigan. Dr. Davis has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Peripheral Artery Disease, Arterial Insufficiency, Atherosclerosis, Atherectomy, and Angioplasty.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
St. George's School Of Medicine, 1986
Residency
Henry Ford Hospital
Specialties
Cardiology
Licenses
Internal Medicine in MI
Board Certifications
American Board Of Internal Medicine
Hospital Affiliations
Corewell Health Beaumont Grosse Pointe Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Rudy J Vervaeke MD PLC
24211 Little Mack Ave, Saint Clair Shores, MI 48080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)
A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study
Enrollment Status: Completed
Publish Date: November 13, 2025
Intervention Type: Device
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard™ Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
A Multicenter, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard™ Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
Enrollment Status: Active_not_recruiting
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Enrollment Status: Unknown
Publish Date: January 23, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat Peripheral Artery Disease
Evaluation of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System to Treat Peripheral Artery Disease
Enrollment Status: Completed
Publish Date: November 04, 2022
Intervention Type: Device
Study Phase: Not Applicable
Feasibility Clinical Trial of the Cardio Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Feasibility Clinical Trial of the Cardio Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Enrollment Status: Completed
Publish Date: May 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Enrollment Status: Completed
Publish Date: November 08, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 13 Less Clinical Trials

20 Total Publications

Genome sequence of bacteriophage Djungelskog isolated from an Arthrobacter globiformis culture.
Genome sequence of bacteriophage Djungelskog isolated from an Arthrobacter globiformis culture.
Journal: Microbiology resource announcements
Published: February 20, 2024
Similar Doctors
Mustafa Hashem
Distinguished in Superficial Thrombophlebitis
Dr. Mustafa Hashem
Cardiology
Distinguished in Superficial Thrombophlebitis
Dr. Mustafa Hashem
Cardiology

Downriver Heart And Vascular Specialists PC

15150 Fort St, 
Southgate, MI 
 (20.8 miles away)
734-282-4650
Experience:
33+ years
Languages Spoken:
English
See accepted insurances

Mustafa Hashem is a Cardiologist in Southgate, Michigan. Dr. Hashem has been practicing medicine for over 33 years and is rated as a Distinguished provider by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Heart Attack, Necrosis, Arterial Embolism, Pacemaker Implantation, and Thrombectomy.

Georges Ghafari
Advanced in Superficial Thrombophlebitis
Dr. Georges Ghafari
Cardiology
Advanced in Superficial Thrombophlebitis
Dr. Georges Ghafari
Cardiology

Rudy J Vervaeke MD PLC

24211 Little Mack Ave, 
Saint Clair Shores, MI 
 (16.6 miles away)
586-226-6700
Experience:
40+ years
Languages Spoken:
English
See accepted insurances

Georges Ghafari is a Cardiologist in Saint Clair Shores, Michigan. Dr. Ghafari has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Angina, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Atherosclerosis.

Advanced in Superficial Thrombophlebitis
Dr. Qaiser Shafiq
Interventional Cardiology | Cardiology
Advanced in Superficial Thrombophlebitis
Dr. Qaiser Shafiq
Interventional Cardiology | Cardiology

Downriver Heart & Vascular Specialists

15150 Fort Street, 
Southgate, MI 
 (20.3 miles away)
734-282-4800
Experience:
24+ years
Languages Spoken:
English, Arabic, Punjabi, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Qaiser Shafiq is a Cardiologist and an Interventional Cardiologist in Southgate, Michigan. Dr. Shafiq has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Superficial Thrombophlebitis. His top areas of expertise are Heart Attack, Apoplexy, Heart Failure, Pacemaker Implantation, and Embolectomy. Dr. Shafiq is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Davis's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile